Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Security

Coya Therapeutics, Inc. Common Stock · COYA

COYANASDAQCommon stockCurrentCIK 1835022Updated Nov 12, 2026

Company: Coya Therapeutics, Inc. →

COYA price & chart

Provider market data

Loading TradingView…

NASDAQ:COYA on TradingView ↗

TradingView · Data may be delayed

About the company

COYA 302 is an investigational and proprietary biologic combination therapy with a dual immunomodulatory mechanism of action intended to enhance the anti-inflammatory function of regulatory T cells (Tregs) and suppress the inflammation produced by activated monocytes and macrophages. COYA 302 comprises proprietary low dose interleukin-2 (LD IL-2) and CTLA-4 Ig and is being developed for subcutaneous administration for the treatment of patients with ALS and other neurodegenerative diseases. These mechanisms may have additive or synergistic effects.

8-K · 2026-11-10 · 0001193125-26-454473

Company description from the cited filing.

In the news

Seeking Alpha

Financials

FY 2025 · USD
Revenue7,945,753USD · FY 2025
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

Net income-21,226,107USD · FY 2025
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

Operating income-22,555,225USD · FY 2025
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

Diluted EPS-1.27USD per share · FY 2025
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2025Q3 2024Q2 2026Q2 2025Q2 2024Q1 2026Q1 2025Q1 2024FY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD32,042,878
Source

10-Q · 2025-11-12 · 0001193125-25-276058

As of 2025-09-30

35,551,830
Source

10-Q · 2024-11-06 · 0000950170-24-121837

As of 2024-09-30

47,308,078
Source

10-Q · 2026-08-11 · 0001193125-26-343481

As of 2026-06-30

33,452,555
Source

10-Q · 2025-08-12 · 0000950170-25-106934

As of 2025-06-30

39,938,615
Source

10-Q · 2024-08-12 · 0000950170-24-095075

As of 2024-06-30

53,271,099
Source

10-Q · 2026-05-12 · 0001193125-26-218201

As of 2026-03-31

38,404,996
Source

10-Q · 2025-05-13 · 0000950170-25-069824

As of 2025-03-31

37,393,470
Source

10-Q · 2024-05-09 · 0000950170-24-057056

As of 2024-03-31

49,950,245
Source

10-K · 2026-03-16 · 0001193125-26-107281

As of 2025-12-31

44,347,016
Source

10-K · 2025-03-18 · 0000950170-25-040782

As of 2024-12-31

41,262,274
Source

10-K · 2024-03-19 · 0000950170-24-033161

As of 2023-12-31

8,395,566
Source

10-K · 2023-03-29 · 0000950170-23-010599

As of 2022-12-31

Property, Plant and Equipment, NetUSD18,068
Source

10-Q · 2025-11-12 · 0001193125-25-276058

As of 2025-09-30

45,429
Source

10-Q · 2024-11-06 · 0000950170-24-121837

As of 2024-09-30

5,614
Source

10-Q · 2026-08-11 · 0001193125-26-343481

As of 2026-06-30

24,908
Source

10-Q · 2025-08-12 · 0000950170-25-106934

As of 2025-06-30

52,269
Source

10-Q · 2024-08-12 · 0000950170-24-095075

As of 2024-06-30

8,420
Source

10-Q · 2026-05-12 · 0001193125-26-218201

As of 2026-03-31

31,748
Source

10-Q · 2025-05-13 · 0000950170-25-069824

As of 2025-03-31

59,109
Source

10-Q · 2024-05-09 · 0000950170-24-057056

As of 2024-03-31

11,227
Source

10-K · 2026-03-16 · 0001193125-26-107281

As of 2025-12-31

38,588
Source

10-K · 2025-03-18 · 0000950170-25-040782

As of 2024-12-31

65,949
Source

10-K · 2024-03-19 · 0000950170-24-033161

As of 2023-12-31

93,310
Source

10-K · 2023-03-29 · 0000950170-23-010599

As of 2022-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD28,129,866
Source

10-Q · 2025-11-12 · 0001193125-25-276058

As of 2025-09-30

31,057,395
Source

10-Q · 2024-11-06 · 0000950170-24-121837

As of 2024-09-30

43,181,002
Source

10-Q · 2026-08-11 · 0001193125-26-343481

As of 2026-06-30

29,757,328
Source

10-Q · 2025-08-12 · 0000950170-25-106934

As of 2025-06-30

36,575,089
Source

10-Q · 2024-08-12 · 0000950170-24-095075

As of 2024-06-30

50,724,643
Source

10-Q · 2026-05-12 · 0001193125-26-218201

As of 2026-03-31

35,530,624
Source

10-Q · 2025-05-13 · 0000950170-25-069824

As of 2025-03-31

35,989,406
Source

10-Q · 2024-05-09 · 0000950170-24-057056

As of 2024-03-31

46,822,786
Source

10-K · 2026-03-16 · 0001193125-26-107281

As of 2025-12-31

38,339,762
Source

10-K · 2025-03-18 · 0000950170-25-040782

As of 2024-12-31

32,626,768
Source

10-K · 2024-03-19 · 0000950170-24-033161

As of 2023-12-31

5,933,702
Source

10-K · 2023-03-29 · 0000950170-23-010599

As of 2022-12-31

Assets, CurrentUSD32,024,810
Source

10-Q · 2025-11-12 · 0001193125-25-276058

As of 2025-09-30

35,506,401
Source

10-Q · 2024-11-06 · 0000950170-24-121837

As of 2024-09-30

47,057,737
Source

10-Q · 2026-08-11 · 0001193125-26-343481

As of 2026-06-30

33,427,647
Source

10-Q · 2025-08-12 · 0000950170-25-106934

As of 2025-06-30

39,886,346
Source

10-Q · 2024-08-12 · 0000950170-24-095075

As of 2024-06-30

53,262,679
Source

10-Q · 2026-05-12 · 0001193125-26-218201

As of 2026-03-31

38,373,248
Source

10-Q · 2025-05-13 · 0000950170-25-069824

As of 2025-03-31

37,334,361
Source

10-Q · 2024-05-09 · 0000950170-24-057056

As of 2024-03-31

49,939,018
Source

10-K · 2026-03-16 · 0001193125-26-107281

As of 2025-12-31

44,308,428
Source

10-K · 2025-03-18 · 0000950170-25-040782

As of 2024-12-31

41,196,325
Source

10-K · 2024-03-19 · 0000950170-24-033161

As of 2023-12-31

7,184,966
Source

10-K · 2023-03-29 · 0000950170-23-010599

As of 2022-12-31

Prepaid Expense and Other Assets, CurrentUSD3,894,944
Source

10-Q · 2025-11-12 · 0001193125-25-276058

As of 2025-09-30

4,449,006
Source

10-Q · 2024-11-06 · 0000950170-24-121837

As of 2024-09-30

3,876,735
Source

10-Q · 2026-08-11 · 0001193125-26-343481

As of 2026-06-30

3,670,319
Source

10-Q · 2025-08-12 · 0000950170-25-106934

As of 2025-06-30

3,311,257
Source

10-Q · 2024-08-12 · 0000950170-24-095075

As of 2024-06-30

2,538,036
Source

10-Q · 2026-05-12 · 0001193125-26-218201

As of 2026-03-31

2,842,624
Source

10-Q · 2025-05-13 · 0000950170-25-069824

As of 2025-03-31

1,344,955
Source

10-Q · 2024-05-09 · 0000950170-24-057056

As of 2024-03-31

3,116,232
Source

10-K · 2026-03-16 · 0001193125-26-107281

As of 2025-12-31

5,968,666
Source

10-K · 2025-03-18 · 0000950170-25-040782

As of 2024-12-31

1,069,557
Source

10-K · 2024-03-19 · 0000950170-24-033161

As of 2023-12-31

1,251,264
Source

10-K · 2023-03-29 · 0000950170-23-010599

As of 2022-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD4,758,387
Source

10-Q · 2025-11-12 · 0001193125-25-276058

As of 2025-09-30

3,541,642
Source

10-Q · 2024-11-06 · 0000950170-24-121837

As of 2024-09-30

4,032,067
Source

10-Q · 2026-08-11 · 0001193125-26-343481

As of 2026-06-30

5,142,262
Source

10-Q · 2025-08-12 · 0000950170-25-106934

As of 2025-06-30

4,682,015
Source

10-Q · 2024-08-12 · 0000950170-24-095075

As of 2024-06-30

4,300,739
Source

10-Q · 2026-05-12 · 0001193125-26-218201

As of 2026-03-31

5,035,439
Source

10-Q · 2025-05-13 · 0000950170-25-069824

As of 2025-03-31

5,000,429
Source

10-Q · 2024-05-09 · 0000950170-24-057056

As of 2024-03-31

6,922,015
Source

10-K · 2026-03-16 · 0001193125-26-107281

As of 2025-12-31

4,769,921
Source

10-K · 2025-03-18 · 0000950170-25-040782

As of 2024-12-31

5,626,665
Source

10-K · 2024-03-19 · 0000950170-24-033161

As of 2023-12-31

16,789,111
Source

10-K · 2023-03-29 · 0000950170-23-010599

As of 2022-12-31

Stockholders’ equity:
Preferred Stock, Value, IssuedUSD———————————8,793,637
Source

10-K · 2023-03-29 · 0000950170-23-010599

As of 2022-12-31

Common Stock, Value, IssuedUSD1,675
Source

10-Q · 2025-11-12 · 0001193125-25-276058

As of 2025-09-30

1,523
Source

10-Q · 2024-11-06 · 0000950170-24-121837

As of 2024-09-30

2,346
Source

10-Q · 2026-08-11 · 0001193125-26-343481

As of 2026-06-30

1,673
Source

10-Q · 2025-08-12 · 0000950170-25-106934

As of 2025-06-30

1,523
Source

10-Q · 2024-08-12 · 0000950170-24-095075

As of 2024-06-30

2,346
Source

10-Q · 2026-05-12 · 0001193125-26-218201

As of 2026-03-31

1,673
Source

10-Q · 2025-05-13 · 0000950170-25-069824

As of 2025-03-31

1,462
Source

10-Q · 2024-05-09 · 0000950170-24-057056

As of 2024-03-31

2,094
Source

10-K · 2026-03-16 · 0001193125-26-107281

As of 2025-12-31

1,671
Source

10-K · 2025-03-18 · 0000950170-25-040782

As of 2024-12-31

1,441
Source

10-K · 2024-03-19 · 0000950170-24-033161

As of 2023-12-31

259
Source

10-K · 2023-03-29 · 0000950170-23-010599

As of 2022-12-31

Additional Paid in CapitalUSD83,537,551
Source

10-Q · 2025-11-12 · 0001193125-25-276058

As of 2025-09-30

69,830,059
Source

10-Q · 2024-11-06 · 0000950170-24-121837

As of 2024-09-30

119,082,192
Source

10-Q · 2026-08-11 · 0001193125-26-343481

As of 2026-06-30

82,447,524
Source

10-Q · 2025-08-12 · 0000950170-25-106934

As of 2025-06-30

69,055,053
Source

10-Q · 2024-08-12 · 0000950170-24-095075

As of 2024-06-30

118,138,281
Source

10-Q · 2026-05-12 · 0001193125-26-218201

As of 2026-03-31

81,411,811
Source

10-Q · 2025-05-13 · 0000950170-25-069824

As of 2025-03-31

63,449,125
Source

10-Q · 2024-05-09 · 0000950170-24-057056

As of 2024-03-31

104,989,413
Source

10-K · 2026-03-16 · 0001193125-26-107281

As of 2025-12-31

80,312,594
Source

10-K · 2025-03-18 · 0000950170-25-040782

As of 2024-12-31

61,501,801
Source

10-K · 2024-03-19 · 0000950170-24-033161

As of 2023-12-31

681,106
Source

10-K · 2023-03-29 · 0000950170-23-010599

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD-56,254,735
Source

10-Q · 2025-11-12 · 0001193125-25-276058

As of 2025-09-30

-37,821,394
Source

10-Q · 2024-11-06 · 0000950170-24-121837

As of 2024-09-30

-75,808,527
Source

10-Q · 2026-08-11 · 0001193125-26-343481

As of 2026-06-30

-54,138,904
Source

10-Q · 2025-08-12 · 0000950170-25-106934

As of 2025-06-30

-33,799,976
Source

10-Q · 2024-08-12 · 0000950170-24-095075

As of 2024-06-30

-69,170,267
Source

10-Q · 2026-05-12 · 0001193125-26-218201

As of 2026-03-31

-48,043,927
Source

10-Q · 2025-05-13 · 0000950170-25-069824

As of 2025-03-31

-30,908,296
Source

10-Q · 2024-05-09 · 0000950170-24-057056

As of 2024-03-31

-61,963,277
Source

10-K · 2026-03-16 · 0001193125-26-107281

As of 2025-12-31

-40,737,170
Source

10-K · 2025-03-18 · 0000950170-25-040782

As of 2024-12-31

-25,856,383
Source

10-K · 2024-03-19 · 0000950170-24-033161

As of 2023-12-31

-17,868,547
Source

10-K · 2023-03-29 · 0000950170-23-010599

As of 2022-12-31

Stockholders' Equity Attributable to ParentUSD27,284,491
Source

10-Q · 2025-11-12 · 0001193125-25-276058

As of 2025-09-30

32,010,188
Source

10-Q · 2025-11-12 · 0001193125-25-276058

As of 2024-09-30

43,276,011
Source

10-Q · 2026-08-11 · 0001193125-26-343481

As of 2026-06-30

28,310,293
Source

10-Q · 2026-08-11 · 0001193125-26-343481

As of 2025-06-30

35,256,600
Source

10-Q · 2025-08-12 · 0000950170-25-106934

As of 2024-06-30

48,970,360
Source

10-Q · 2026-05-12 · 0001193125-26-218201

As of 2026-03-31

33,369,557
Source

10-Q · 2026-05-12 · 0001193125-26-218201

As of 2025-03-31

32,393,041
Source

10-Q · 2025-05-13 · 0000950170-25-069824

As of 2024-03-31

43,028,230
Source

10-K · 2026-03-16 · 0001193125-26-107281

As of 2025-12-31

39,577,095
Source

10-K · 2025-03-18 · 0000950170-25-040782

As of 2024-12-31

35,635,609
Source

10-K · 2024-03-19 · 0000950170-24-033161

As of 2023-12-31

-8,393,545
Source

10-K · 2023-03-29 · 0000950170-23-010599

As of 2022-12-31

Liabilities and EquityUSD32,042,878
Source

10-Q · 2025-11-12 · 0001193125-25-276058

As of 2025-09-30

35,551,830
Source

10-Q · 2024-11-06 · 0000950170-24-121837

As of 2024-09-30

47,308,078
Source

10-Q · 2026-08-11 · 0001193125-26-343481

As of 2026-06-30

33,452,555
Source

10-Q · 2025-08-12 · 0000950170-25-106934

As of 2025-06-30

39,938,615
Source

10-Q · 2024-08-12 · 0000950170-24-095075

As of 2024-06-30

53,271,099
Source

10-Q · 2026-05-12 · 0001193125-26-218201

As of 2026-03-31

38,404,996
Source

10-Q · 2025-05-13 · 0000950170-25-069824

As of 2025-03-31

37,393,470
Source

10-Q · 2024-05-09 · 0000950170-24-057056

As of 2024-03-31

49,950,245
Source

10-K · 2026-03-16 · 0001193125-26-107281

As of 2025-12-31

44,347,016
Source

10-K · 2025-03-18 · 0000950170-25-040782

As of 2024-12-31

41,262,274
Source

10-K · 2024-03-19 · 0000950170-24-033161

As of 2023-12-31

8,395,566
Source

10-K · 2023-03-29 · 0000950170-23-010599

As of 2022-12-31

Current liabilities:
Liabilities, CurrentUSD3,667,120
Source

10-Q · 2025-11-12 · 0001193125-25-276058

As of 2025-09-30

2,319,046
Source

10-Q · 2024-11-06 · 0000950170-24-121837

As of 2024-09-30

3,512,431
Source

10-Q · 2026-08-11 · 0001193125-26-343481

As of 2026-06-30

4,501,104
Source

10-Q · 2025-08-12 · 0000950170-25-106934

As of 2025-06-30

3,825,365
Source

10-Q · 2024-08-12 · 0000950170-24-095075

As of 2024-06-30

3,546,541
Source

10-Q · 2026-05-12 · 0001193125-26-218201

As of 2026-03-31

4,341,004
Source

10-Q · 2025-05-13 · 0000950170-25-069824

As of 2025-03-31

4,319,142
Source

10-Q · 2024-05-09 · 0000950170-24-057056

As of 2024-03-31

5,871,891
Source

10-K · 2026-03-16 · 0001193125-26-107281

As of 2025-12-31

3,824,474
Source

10-K · 2025-03-18 · 0000950170-25-040782

As of 2024-12-31

5,051,980
Source

10-K · 2024-03-19 · 0000950170-24-033161

As of 2023-12-31

3,823,631
Source

10-K · 2023-03-29 · 0000950170-23-010599

As of 2022-12-31

Accounts Payable, CurrentUSD1,111,702
Source

10-Q · 2025-11-12 · 0001193125-25-276058

As of 2025-09-30

336,722
Source

10-Q · 2024-11-06 · 0000950170-24-121837

As of 2024-09-30

1,085,519
Source

10-Q · 2026-08-11 · 0001193125-26-343481

As of 2026-06-30

931,344
Source

10-Q · 2025-08-12 · 0000950170-25-106934

As of 2025-06-30

1,883,077
Source

10-Q · 2024-08-12 · 0000950170-24-095075

As of 2024-06-30

948,192
Source

10-Q · 2026-05-12 · 0001193125-26-218201

As of 2026-03-31

1,690,007
Source

10-Q · 2025-05-13 · 0000950170-25-069824

As of 2025-03-31

1,587,943
Source

10-Q · 2024-05-09 · 0000950170-24-057056

As of 2024-03-31

1,061,122
Source

10-K · 2026-03-16 · 0001193125-26-107281

As of 2025-12-31

1,588,128
Source

10-K · 2025-03-18 · 0000950170-25-040782

As of 2024-12-31

1,155,656
Source

10-K · 2024-03-19 · 0000950170-24-033161

As of 2023-12-31

1,815,270
Source

10-K · 2023-03-29 · 0000950170-23-010599

As of 2022-12-31

Additional Financial Items
Accrued Liabilities, CurrentUSD1,638,706
Source

10-Q · 2025-11-12 · 0001193125-25-276058

As of 2025-09-30

1,409,235
Source

10-Q · 2024-11-06 · 0000950170-24-121837

As of 2024-09-30

1,193,460
Source

10-Q · 2026-08-11 · 0001193125-26-343481

As of 2026-06-30

2,838,685
Source

10-Q · 2025-08-12 · 0000950170-25-106934

As of 2025-06-30

1,003,253
Source

10-Q · 2024-08-12 · 0000950170-24-095075

As of 2024-06-30

1,355,714
Source

10-Q · 2026-05-12 · 0001193125-26-218201

As of 2026-03-31

1,809,583
Source

10-Q · 2025-05-13 · 0000950170-25-069824

As of 2025-03-31

2,041,530
Source

10-Q · 2024-05-09 · 0000950170-24-057056

As of 2024-03-31

3,612,913
Source

10-K · 2026-03-16 · 0001193125-26-107281

As of 2025-12-31

1,388,060
Source

10-K · 2025-03-18 · 0000950170-25-040782

As of 2024-12-31

2,973,215
Source

10-K · 2024-03-19 · 0000950170-24-033161

As of 2023-12-31

2,008,361
Source

10-K · 2023-03-29 · 0000950170-23-010599

As of 2022-12-31

Deferred Revenue, CurrentUSD916,712
Source

10-Q · 2025-11-12 · 0001193125-25-276058

As of 2025-09-30

573,089
Source

10-Q · 2024-11-06 · 0000950170-24-121837

As of 2024-09-30

1,233,452
Source

10-Q · 2026-08-11 · 0001193125-26-343481

As of 2026-06-30

731,075
Source

10-Q · 2025-08-12 · 0000950170-25-106934

As of 2025-06-30

939,035
Source

10-Q · 2024-08-12 · 0000950170-24-095075

As of 2024-06-30

1,242,635
Source

10-Q · 2026-05-12 · 0001193125-26-218201

As of 2026-03-31

841,414
Source

10-Q · 2025-05-13 · 0000950170-25-069824

As of 2025-03-31

689,669
Source

10-Q · 2024-05-09 · 0000950170-24-057056

As of 2024-03-31

1,197,856
Source

10-K · 2026-03-16 · 0001193125-26-107281

As of 2025-12-31

848,286
Source

10-K · 2025-03-18 · 0000950170-25-040782

As of 2024-12-31

923,109
Source

10-K · 2024-03-19 · 0000950170-24-033161

As of 2023-12-31

—
Deferred Tax Liabilities, NetUSD———————————60
Source

10-K · 2023-03-29 · 0000950170-23-010599

As of 2022-12-31

Other Assets, Noncurrent———
Source

10-Q · 2026-08-11 · 0001193125-26-343481

As of 2026-06-30

—————————

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD——————-7,206,990
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2026-01-01 to 2026-03-31

-7,306,757
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2025-01-01 to 2025-03-31

-21,226,107
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

-14,880,787
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

-7,987,836
Source

10-K · 2024-03-19 · 0000950170-24-033161

2023-01-01 to 2023-12-31

-12,244,776
Source

10-K · 2023-03-29 · 0000950170-23-010599

2022-01-01 to 2022-12-31

Adjustments to reconcile net income to net cash provided by operating activities:
Share-based Payment Arrangement, Noncash ExpenseUSD——————2,195,516
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2026-01-01 to 2026-03-31

1,080,082
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2025-01-01 to 2025-03-31

4,290,315
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

2,663,539
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

872,248
Source

10-K · 2024-03-19 · 0000950170-24-033161

2023-01-01 to 2023-12-31

207,346
Source

10-K · 2023-03-29 · 0000950170-23-010599

2022-01-01 to 2022-12-31

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts PayableUSD——————-154,713
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2026-01-01 to 2026-03-31

101,879
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2025-01-01 to 2025-03-31

-527,006
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

477,450
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

298,816
Source

10-K · 2024-03-19 · 0000950170-24-033161

2023-01-01 to 2023-12-31

845,284
Source

10-K · 2023-03-29 · 0000950170-23-010599

2022-01-01 to 2022-12-31

Net Cash Provided by (Used in) Operating ActivitiesUSD——————-6,208,530
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2026-01-01 to 2026-03-31

-2,828,275
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2025-01-01 to 2025-03-31

-10,739,301
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

-10,288,822
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

-11,188,811
Source

10-K · 2024-03-19 · 0000950170-24-033161

2023-01-01 to 2023-12-31

-7,239,354
Source

10-K · 2023-03-29 · 0000950170-23-010599

2022-01-01 to 2022-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD——————-885,000
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2026-01-01 to 2026-03-31

—-1,164,602
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

-25,000
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

-543,186
Source

10-K · 2024-03-19 · 0000950170-24-033161

2023-01-01 to 2023-12-31

-525,000
Source

10-K · 2023-03-29 · 0000950170-23-010599

2022-01-01 to 2022-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD——————10,995,387
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2026-01-01 to 2026-03-31

19,137
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2025-01-01 to 2025-03-31

20,386,927
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

16,026,816
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

38,425,063
Source

10-K · 2024-03-19 · 0000950170-24-033161

2023-01-01 to 2023-12-31

9,357,878
Source

10-K · 2023-03-29 · 0000950170-23-010599

2022-01-01 to 2022-12-31

Supplemental disclosure of cash flow information:
Income Taxes Paid, NetUSD————————-730,581
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

———
Additional Financial Items
Share-based Payment Arrangement, ExpenseUSD——1,070,892
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2025-07-01 to 2025-09-30

775,006
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2024-07-01 to 2024-09-30

943,911
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2026-04-01 to 2026-06-30

1,035,713
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2025-04-01 to 2025-06-30

2,195,516
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2026-01-01 to 2026-03-31

1,080,082
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2025-01-01 to 2025-03-31

4,290,315
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

2,663,539
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

872,248
Source

10-K · 2024-03-19 · 0000950170-24-033161

2023-01-01 to 2023-12-31

207,346
Source

10-K · 2023-03-29 · 0000950170-23-010599

2022-01-01 to 2022-12-31

Amortization of Debt Issuance CostsUSD———————————997,367
Source

10-K · 2023-03-29 · 0000950170-23-010599

2022-01-01 to 2022-12-31

DepreciationUSD——6,840
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2025-07-01 to 2025-09-30

6,841
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2024-07-01 to 2024-09-30

2,807
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2026-04-01 to 2026-06-30

6,840
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2025-04-01 to 2025-06-30

2,807
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2026-01-01 to 2026-03-31

6,840
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2025-01-01 to 2025-03-31

27,361
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

27,361
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

27,361
Source

10-K · 2024-03-19 · 0000950170-24-033161

2023-01-01 to 2023-12-31

27,361
Source

10-K · 2023-03-29 · 0000950170-23-010599

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD——2,557,440
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2025-07-01 to 2025-09-30

2,219,545
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2024-07-01 to 2024-09-30

2,255,603
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2026-04-01 to 2026-06-30

2,908,191
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2025-04-01 to 2025-06-30

3,781,977
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2026-01-01 to 2026-03-31

2,713,890
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2025-01-01 to 2025-03-31

11,449,466
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

8,885,757
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

7,833,481
Source

10-K · 2024-03-19 · 0000950170-24-033161

2023-01-01 to 2023-12-31

4,847,080
Source

10-K · 2023-03-29 · 0000950170-23-010599

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD—————0
Source

10-Q · 2025-08-12 · 0000950170-25-106934

2025-04-01 to 2025-06-30

——3,089
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

-720,287
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

723,852
Source

10-K · 2024-03-19 · 0000950170-24-033161

2023-01-01 to 2023-12-31

—
Net Income (Loss) Attributable to ParentUSD——-2,115,831
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2025-07-01 to 2025-09-30

-4,021,418
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2024-07-01 to 2024-09-30

-6,638,260
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2026-04-01 to 2026-06-30

-6,094,977
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2025-04-01 to 2025-06-30

-7,206,990
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2026-01-01 to 2026-03-31

-7,306,757
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2025-01-01 to 2025-03-31

-21,226,107
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

-14,880,787
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

-7,987,836
Source

10-K · 2024-03-19 · 0000950170-24-033161

2023-01-01 to 2023-12-31

-12,244,776
Source

10-K · 2023-03-29 · 0000950170-23-010599

2022-01-01 to 2022-12-31

Operating ExpensesUSD——5,997,151
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2025-07-01 to 2025-09-30

4,450,289
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2024-07-01 to 2024-09-30

7,290,733
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2026-04-01 to 2026-06-30

6,578,134
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2025-04-01 to 2025-06-30

7,891,364
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2026-01-01 to 2026-03-31

7,934,806
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2025-01-01 to 2025-03-31

30,500,978
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

20,803,772
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

13,905,555
Source

10-K · 2024-03-19 · 0000950170-24-033161

2023-01-01 to 2023-12-31

9,811,939
Source

10-K · 2023-03-29 · 0000950170-23-010599

2022-01-01 to 2022-12-31

Other Nonoperating Income (Expense)USD——317,066
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2025-07-01 to 2025-09-30

428,871
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2024-07-01 to 2024-09-30

408,728
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2026-04-01 to 2026-06-30

319,541
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2025-04-01 to 2025-06-30

433,227
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2026-01-01 to 2026-03-31

370,165
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2025-01-01 to 2025-03-31

1,332,207
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

1,648,637
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

639,365
Source

10-K · 2024-03-19 · 0000950170-24-033161

2023-01-01 to 2023-12-31

63,673
Source

10-K · 2023-03-29 · 0000950170-23-010599

2022-01-01 to 2022-12-31

Proceeds from Issuance of Common StockUSD——————10,995,387
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2026-01-01 to 2026-03-31

—20,348,653
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

14,004,381
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

——
Proceeds from Stock Options ExercisedUSD———————19,137
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2025-01-01 to 2025-03-31

38,274
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

1,975
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

89,947
Source

10-K · 2024-03-19 · 0000950170-24-033161

2023-01-01 to 2023-12-31

158
Source

10-K · 2023-03-29 · 0000950170-23-010599

2022-01-01 to 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Total RevenueUSD——3,564,254
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2025-07-01 to 2025-09-30

—243,745
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2026-04-01 to 2026-06-30

163,616
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2025-04-01 to 2025-06-30

251,147
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2026-01-01 to 2026-03-31

257,884
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2025-01-01 to 2025-03-31

7,945,753
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

3,554,061
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

6,002,206
Source

10-K · 2024-03-19 · 0000950170-24-033161

2023-01-01 to 2023-12-31

—
Operating Income (Loss)USD——-2,432,897
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2025-07-01 to 2025-09-30

-4,450,289
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2024-07-01 to 2024-09-30

-7,046,988
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2026-04-01 to 2026-06-30

-6,414,518
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2025-04-01 to 2025-06-30

-7,640,217
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2026-01-01 to 2026-03-31

-7,676,922
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2025-01-01 to 2025-03-31

-22,555,225
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

-17,249,711
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

-7,903,349
Source

10-K · 2024-03-19 · 0000950170-24-033161

2023-01-01 to 2023-12-31

-9,811,939
Source

10-K · 2023-03-29 · 0000950170-23-010599

2022-01-01 to 2022-12-31

Other Nonoperating Income (Expense)USD——317,066
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2025-07-01 to 2025-09-30

428,871
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2024-07-01 to 2024-09-30

408,728
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2026-04-01 to 2026-06-30

319,541
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2025-04-01 to 2025-06-30

433,227
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2026-01-01 to 2026-03-31

370,165
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2025-01-01 to 2025-03-31

1,332,207
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

1,648,637
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

639,365
Source

10-K · 2024-03-19 · 0000950170-24-033161

2023-01-01 to 2023-12-31

63,673
Source

10-K · 2023-03-29 · 0000950170-23-010599

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD————-6,638,260
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2026-04-01 to 2026-06-30

-6,094,977
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2025-04-01 to 2025-06-30

-7,206,990
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2026-01-01 to 2026-03-31

-7,306,757
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2025-01-01 to 2025-03-31

-21,223,018
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

-15,601,074
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

-7,263,984
Source

10-K · 2024-03-19 · 0000950170-24-033161

2023-01-01 to 2023-12-31

—
Income Tax Expense (Benefit)USD—————0
Source

10-Q · 2025-08-12 · 0000950170-25-106934

2025-04-01 to 2025-06-30

——3,089
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

-720,287
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

723,852
Source

10-K · 2024-03-19 · 0000950170-24-033161

2023-01-01 to 2023-12-31

—
Net Income (Loss) Attributable to ParentUSD——-2,115,831
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2025-07-01 to 2025-09-30

-4,021,418
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2024-07-01 to 2024-09-30

-6,638,260
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2026-04-01 to 2026-06-30

-6,094,977
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2025-04-01 to 2025-06-30

-7,206,990
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2026-01-01 to 2026-03-31

-7,306,757
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2025-01-01 to 2025-03-31

-21,226,107
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

-14,880,787
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

-7,987,836
Source

10-K · 2024-03-19 · 0000950170-24-033161

2023-01-01 to 2023-12-31

-12,244,776
Source

10-K · 2023-03-29 · 0000950170-23-010599

2022-01-01 to 2022-12-31

Earnings Per Share, BasicUSD per share——-0.13
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2025-07-01 to 2025-09-30

-0.26
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2024-07-01 to 2024-09-30

-0.28
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2026-04-01 to 2026-06-30

-0.36
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2025-04-01 to 2025-06-30

-0.32
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2026-01-01 to 2026-03-31

-0.44
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2025-01-01 to 2025-03-31

-1.27
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

-0.98
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

-0.79
Source

10-K · 2024-03-19 · 0000950170-24-033161

2023-01-01 to 2023-12-31

-4.73
Source

10-K · 2023-03-29 · 0000950170-23-010599

2022-01-01 to 2022-12-31

Earnings Per Share, DilutedUSD per share——-0.13
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2025-07-01 to 2025-09-30

-0.26
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2024-07-01 to 2024-09-30

-0.28
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2026-04-01 to 2026-06-30

-0.36
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2025-04-01 to 2025-06-30

-0.32
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2026-01-01 to 2026-03-31

-0.44
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2025-01-01 to 2025-03-31

-1.27
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

-0.98
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

-0.79
Source

10-K · 2024-03-19 · 0000950170-24-033161

2023-01-01 to 2023-12-31

-4.73
Source

10-K · 2023-03-29 · 0000950170-23-010599

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Basicshares——16,732,766
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2025-07-01 to 2025-09-30

15,221,308
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2024-07-01 to 2024-09-30

23,457,227
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2026-04-01 to 2026-06-30

16,724,998
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2025-04-01 to 2025-06-30

22,644,304
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2026-01-01 to 2026-03-31

16,720,511
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2025-01-01 to 2025-03-31

16,730,274
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

15,238,919
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

10,163,850
Source

10-K · 2024-03-19 · 0000950170-24-033161

2023-01-01 to 2023-12-31

2,590,173
Source

10-K · 2023-03-29 · 0000950170-23-010599

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares——16,732,766
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2025-07-01 to 2025-09-30

15,221,308
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2024-07-01 to 2024-09-30

23,457,227
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2026-04-01 to 2026-06-30

16,724,998
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2025-04-01 to 2025-06-30

22,644,304
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2026-01-01 to 2026-03-31

16,720,511
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2025-01-01 to 2025-03-31

16,730,274
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

15,238,919
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

10,163,850
Source

10-K · 2024-03-19 · 0000950170-24-033161

2023-01-01 to 2023-12-31

2,590,173
Source

10-K · 2023-03-29 · 0000950170-23-010599

2022-01-01 to 2022-12-31

Additional Financial Items
General and Administrative ExpenseUSD——2,557,440
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2025-07-01 to 2025-09-30

2,219,545
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2024-07-01 to 2024-09-30

2,255,603
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2026-04-01 to 2026-06-30

2,908,191
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2025-04-01 to 2025-06-30

3,781,977
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2026-01-01 to 2026-03-31

2,713,890
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2025-01-01 to 2025-03-31

11,449,466
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

8,885,757
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

7,833,481
Source

10-K · 2024-03-19 · 0000950170-24-033161

2023-01-01 to 2023-12-31

4,847,080
Source

10-K · 2023-03-29 · 0000950170-23-010599

2022-01-01 to 2022-12-31

Labor and Related ExpenseUSD——693,053
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2025-07-01 to 2025-09-30

669,738
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2024-07-01 to 2024-09-30

562,435
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2026-04-01 to 2026-06-30

684,844
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2025-04-01 to 2025-06-30

731,673
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2026-01-01 to 2026-03-31

684,083
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2025-01-01 to 2025-03-31

3,100,930
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

2,685,556
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

——
Operating ExpensesUSD——5,997,151
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2025-07-01 to 2025-09-30

4,450,289
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2024-07-01 to 2024-09-30

7,290,733
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2026-04-01 to 2026-06-30

6,578,134
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2025-04-01 to 2025-06-30

7,891,364
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2026-01-01 to 2026-03-31

7,934,806
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2025-01-01 to 2025-03-31

30,500,978
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

20,803,772
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

13,905,555
Source

10-K · 2024-03-19 · 0000950170-24-033161

2023-01-01 to 2023-12-31

9,811,939
Source

10-K · 2023-03-29 · 0000950170-23-010599

2022-01-01 to 2022-12-31

Other General and Administrative ExpenseUSD——1,181,993
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2025-07-01 to 2025-09-30

1,076,683
Source

10-Q · 2025-11-12 · 0001193125-25-276058

2024-07-01 to 2024-09-30

1,180,922
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2026-04-01 to 2026-06-30

1,545,421
Source

10-Q · 2026-08-11 · 0001193125-26-343481

2025-04-01 to 2025-06-30

1,290,436
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2026-01-01 to 2026-03-31

1,334,414
Source

10-Q · 2026-05-12 · 0001193125-26-218201

2025-01-01 to 2025-03-31

5,546,363
Source

10-K · 2026-03-16 · 0001193125-26-107281

2025-01-01 to 2025-12-31

4,611,534
Source

10-K · 2025-03-18 · 0000950170-25-040782

2024-01-01 to 2024-12-31

——

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

coya-ex99_1.htm · 8-K · 2026-11-10

Exhibit 99.1 Coya Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update HOUSTON--(BUSINESS WIRE)-- Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with neurodegenerative disorders, announces its financial results for the quarter ended September 30, 2026 and provides a corporate update. “Completion of enrollment in our Phase 2/…

8-K · 2026-11-10 · 0001193125-26-454473

Read attachment ↗
coya-ex99_1.htm · 8-K · 2026-08-11

EX-99.1 2 coya-ex99_1.htm EX-99.1 EX-99.1 Coya Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update HOUSTON, TX., August 11, 2026 (BUSINESS WIRE)-- Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with neurodegenerative disorders, announces its financial results for the quarter ended June 30, 2026 and provides a corporate …

8-K · 2026-08-11 · 0001193125-26-343473

Read attachment ↗
coya-ex99_1.htm · 8-K · 2026-05-12

EX-99.1 2 coya-ex99_1.htm EX-99.1 EX-99.1 Coya Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update HOUSTON, TX., May 12, 2026 (BUSINESS WIRE)-- Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with neurodegenerative disorders, announces its financial results for the quarter ended March 31, 2026 and provides a corporate upd…

8-K · 2026-05-12 · 0001193125-26-218198

Read attachment ↗
d104763dex991.htm · 8-K · 2026-04-02

EX-99.1 3 d104763dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Coya Therapeutics Announces Planned Board Transition and Appointment of Mark H. Pavao as Independent Director Howard Berman, Ph. D., the Company’s Founder and current Executive Chairman and Director, has stepped down from his roles, following the CEO transition process initiated in November 2024. ────────────────────────────────────────────────────────────────────────────────────────────────────────────── Mark H. Pavao, a se…

8-K · 2026-04-02 · 0001193125-26-139094

Read attachment ↗
d88735dex991.htm · 8-K · 2026-01-30

Exhibit 99.1 Coya Therapeutics Announces $11.1 Million Private Placement - Dr. Reddy’s Laboratories, Inc. a subsidiary of Coya’s current strategic collaborator, makes a $10 million investment - Greenlight Capital, is the only other investor participating in the offering HOUSTON, TX, January 30, 2026/ Coya Therapeutics, Inc. (Nasdaq: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patient…

8-K · 2026-01-30 · 0001193125-26-030531

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.